Ratings by Credit Suisse (Dan Leonard)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/16/2023 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 8/10/2023 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/10/2023 | Certara Inc. | CERT | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2023 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2023 | Bio-Rad Labs | BIO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2023 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/24/2023 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 5/23/2023 | Maravai LifeScience Holdings Inc. | MRVI | Downgrade | Neutral (Outperform) |
13.38 (8.29) |
-38.04% | Details | |
| 5/12/2023 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2023 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 5/9/2023 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 5/5/2023 | Bio-Rad Labs | BIO | Maintain | Outperform (N/A) |
|
Details | ||
| 4/26/2023 | Danaher | DHR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/27/2023 | Certara Inc. | CERT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2023 | Certara Inc. | CERT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 3/1/2023 | Agilent | A | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2023 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 2/23/2023 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2023 | Bio-Rad Labs | BIO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/10/2023 | Exact Sciences | EXAS | Downgrade | Neutral (Outperform) |
67.82 (104.91) |
54.69% | Details | |
| 2/1/2023 | Thermo Fisher Scientific | TMO | Maintain | Neutral (N/A) |
|
Details | ||
| 1/5/2023 | Danaher | DHR | Downgrade | Neutral (Outperform) |
262.27 (215.91) |
-17.68% | Details | |
| 11/14/2022 | Fulgent Genetics | FLGT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Certara Inc. | CERT | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | Natera | NTRA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/14/2022 | PerkinElmer | PKI | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2022 | Guardant Health | GH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2022 | Illumina | ILMN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2022 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Charles River Labs | CRL | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2022 | Avantor Inc. | AVTR | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2022 | Bio-Rad Labs | BIO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/27/2022 | IQVIA Holdings | IQV | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2022 | Danaher | DHR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2022 | Waters Corp. | WAT | New Coverage | Neutral (N/A) |
314.83 (404.69) |
28.54% | Details | |
| 8/25/2022 | Thermo Fisher Scientific | TMO | New Coverage | Neutral (N/A) |
572.97 (627.55) |
9.53% | Details | |
| 8/25/2022 | PerkinElmer | PKI | New Coverage | Neutral (N/A) |
141.15 (115.24) |
-18.36% | Details | |
| 8/25/2022 | Natera | NTRA | New Coverage | Outperform (N/A) |
50.24 (324.84) |
546.58% | Details | |
| 8/25/2022 | Maravai LifeScience Holdings Inc. | MRVI | New Coverage | Outperform (N/A) |
23.86 (8.29) |
-65.26% | Details | |
| 8/25/2022 | IQVIA Holdings | IQV | New Coverage | Outperform (N/A) |
229.24 (256.05) |
11.7% | Details | |
| 8/25/2022 | Invitae Corporation | NVTA | New Coverage | Underperform (N/A) |
3.41 (0.02) |
-99.41% | Details | |
| 8/25/2022 | Illumina | ILMN | New Coverage | Neutral (N/A) |
194.84 (213.24) |
9.44% | Details | |
| 8/25/2022 | ICON plc | ICLR | New Coverage | Neutral (N/A) |
224.92 (174.27) |
-22.52% | Details | |
| 8/25/2022 | Guardant Health | GH | New Coverage | Outperform (N/A) |
47.97 (167.88) |
249.97% | Details | |
| 8/25/2022 | Fulgent Genetics | FLGT | New Coverage | Outperform (N/A) |
46.96 (19.92) |
-57.58% | Details | |
| 8/25/2022 | Exact Sciences | EXAS | New Coverage | Outperform (N/A) |
35.92 (104.91) |
192.07% | Details | |
| 8/25/2022 | Danaher | DHR | New Coverage | Outperform (N/A) |
284.04 (215.91) |
-23.99% | Details | |
| 8/25/2022 | Charles River Labs | CRL | New Coverage | Outperform (N/A) |
210.81 (291.45) |
38.25% | Details | |
| 8/25/2022 | Certara Inc. | CERT | New Coverage | Outperform (N/A) |
16.40 (8.73) |
-46.77% | Details | |
| 8/25/2022 | Bio-Techne Corp. | TECH | New Coverage | Outperform (N/A) |
342.13 (72.28) |
-78.87% | Details | |
| 8/25/2022 | Bio-Rad Labs | BIO | New Coverage | Outperform (N/A) |
494.62 (376.46) |
-23.89% | Details | |
| 8/25/2022 | Avantor Inc. | AVTR | New Coverage | Neutral (N/A) |
26.04 (14.25) |
-45.28% | Details | |
| 8/25/2022 | Agilent | A | New Coverage | Outperform (N/A) |
132.64 (156.30) |
17.84% | Details | |
| 8/25/2022 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Underperform (N/A) |
10.75 (25.44) |
136.65% | Details |
